Theravance Biopharma Inc (NAS:TBPH)
$ 9.85 0.46 (4.9%) Market Cap: 479.04 Mil Enterprise Value: 399.84 Mil PE Ratio: 0 PB Ratio: 2.33 GF Score: 47/100

Q1 2019 Theravance Biopharma Inc Earnings Call Transcript

May 07, 2019 / 09:00PM GMT
Release Date Price: $24.45 (-2.55%)
Operator

Ladies and gentlemen, good afternoon. At this time, I'd like to welcome everyone to the Theravance Biopharma Conference Call. (Operator Instructions) Today's conference call is being recorded.

And now I would like to turn the call over to Jessica Stitt, Vice President, Finance and Investor Relations. Please go ahead.

Jessica Stitt
Theravance Biopharma, Inc. - VP of Finance & Investor Relations

Good afternoon, everyone, and thank you for joining our conference call and webcast to discuss our first quarter 2019 financial results and outlook. Joining us are Rick Winningham, Chief Executive Officer; Brett Haumann, Chief Medical Officer; and Frank Pasqualone, Chief Commercial Operations Officer. Following some prepared remarks, we will open the call for questions. A copy of the press release and the slides accompanying this call can be downloaded from our website, or you can call Investor Relations at (650) 808-4045, and we'll be happy to assist you.

As always, I will remind you that this conference call will contain forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot